Skip to main content
04/07/2006 - 22:00

Atwill narrows focus at C3

04/07/2006 - 22:00

Bookmark

Save articles for future reference.

Newly-appointed Clinical Cell Culture chief executive Bob Atwill believes the company’s more focused sales and marketing approach will ultimately reap benefits for long-suffering shareholders.

X

To read our articles you will need to either login or subscribe.